Calvert Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-143,975
Closed -$10.8M 792
2016
Q1
$10.8M Buy
143,975
+69,242
+93% +$5.22M 0.48% 56
2015
Q4
$5.75M Buy
+74,733
New +$5.63M 0.26% 76
2015
Q3
Sell
-502,946
Closed -$37.3M 624
2015
Q2
$37.3M Buy
502,946
+304,407
+153% +$23.3M 1.65% 11
2015
Q1
$15.5M Buy
198,539
+19,724
+11% +$1.49M 1% 20
2014
Q4
$12.9M Sell
178,815
-64,845
-27% -$4.5M 0.88% 25
2014
Q3
$15.1M Sell
243,660
-164,662
-40% -$10.5M 1.12% 16
2014
Q2
$26M Buy
408,322
+125,449
+44% +$7.62M 1.75% 10
2014
Q1
$17.4M Buy
282,873
+55,775
+25% +$3.25M 1.23% 21
2013
Q4
$13M Buy
227,098
+137,128
+152% +$7.78M 0.95% 30
2013
Q3
$4.79M Sell
89,970
-501
-0.6% -$27K 0.6% 62
2013
Q2
$4.66M Buy
+90,471
New +$4.47M 0.63% 55

Other funds holding MDT

Calvert Investment Management's MDT Position: Q2 2016 in Review

Calvert Investment Management sold out of Medtronic (MDT) in Q2 2016, closing a stake of 143,975 shares — an estimated $10.8M sold.

Calvert Investment Management first reported a position in MDT in Q2 2013 and held it in 11 quarters. The position peaked at $37.3M in Q2 2015. 1,262 funds tracked by Wall St. Rank hold MDT as of Q2 2016.

  • Calvert Investment Management reported no remaining Medtronic position as of Q2 2016 after selling out during the quarter.
  • Calvert Investment Management sold 143,975 Medtronic shares in Q2 2016, an estimated $10.8M.
  • Calvert Investment Management first reported a position in Medtronic in Q2 2013 and held it in 11 quarters.
  • Calvert Investment Management's Medtronic position peaked at $37.3M in Q2 2015.
  • 1,262 funds tracked by Wall St. Rank held Medtronic as of Q2 2016.

Based on Calvert Investment Management's 13F filing for Q2 2016, filed 4 Aug 2016.